THLD Financial Facts

General and administrative: 2.48M
Total operating expenses: 11.14M
See Full Income Statement

Marketable securities: 56.57M
Additional paid-in capital: 331.22M
See Full Balance Sheet

Threshold Pharmaceuticals, Inc. (THLD) Earnings

  |   Expand Research on THLD
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +1.6% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +0.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/6/14 Q413 -$0.13-$0.10 -$0.03$3.2M$3.58M N/A Details
11/4/13 Q313 $0.02-$0.14 +$0.16$3.2M$3.15M N/A Details
5/2/13 Q113 -$0.16-$0.09 -$0.07$2.9M$2.8M N/A Details
11/2/12 Q312 -$0.06-$0.06 $0.00$1.8M$2.29M N/A Details
5/3/12 Q112 -$2.12N/A N/A N/A$15.65M N/A Details
11/3/11 Q311 -$0.08-$0.15 +$0.07N/AN/A N/A Details